Skip to content


This site uses cookies that need consent. Learn more

Accept Ignore

BakerHicks awarded new Medicines Manufacturing Innovation Centre design .

News 29 Jan 2019

BakerHicks, the multi-disciplinary design and engineering company, have been awarded the contract to deliver design services for the new Medicines Manufacturing Innovation Centre (MMIC) in Renfrewshire, Scotland.

Highlights .

  • Providing academics, research scientists and manufacturing partners with access to cutting-edge equipment and knowledge
  • Increasing productivity in medicines manufacturing
  • Creating local jobs and attracting R&D investment

BakerHicks were appointed by CPI to provide multi-disciplinary design services, including pharmaceutical consultancy, architecture, civil and structural, mechanical and electrical and process engineering, to RIBA Stage 3. Working closely with the CPI team and stakeholders, they will develop the design to the point where it can be tendered for design and build.

The MMIC is a collaboration between CPI, the University of Strathclyde, Innovate UK, Scottish Enterprise, GSK and AstraZeneca. It will provide a research, development and manufacturing facility that will support the UK’s pharmaceutical and fine chemicals industries in accelerating a new generation of manufacturing processes. The Centre is supported by a £13 million investment from UK Research and Innovation through the Industrial Strategy Challenge Fund (ISCF), along with £15 million from Scottish Enterprise and £7 million from both GSK and AstraZeneca.

The pharmaceutical industry is a huge contributor to Scotland’s economy and it’s a real growth sector for our business within the region. I’m excited to be involved in this innovation centre, which will help create local jobs and attract research and development investment that will be a real boost to Scotland.
Laura James Head of Scotland

The MMIC will provide academics, research scientists and manufacturing partners with access to cutting-edge technical equipment and knowledge. It aims to encourage collaboration to develop new technologies and processes that will increase productivity in medicines manufacturing. Work on the facility design is due to start in January 2019.

Related news .